Презентация на тему Superficial femoral artery stents - bare, covered, or drug-coated

Literature -

Justifiable for patients with critical limb ischemia

53% claudication
- only 1 stent implanted
JVS -

67% male
- 66% claudication
- TASC

Stents used in 37% of procedures

Assisted primary patency not higher
than primary patency

JVS - 2005

success

- Improved ABI

- Patency dependent on

Self-Expanding nitinol stents in the FP segment: technique and

3.5
18m 66 4
24m 60 5
137
65
42
20
Mewissen MW. Self-Expanding

Self-Expanding Nitinol Stents in the FP Segment: Technique and Mid-term Results

Technical success
98%
Complications
N=2 (2%)

137 FP Lesions (122 pts)
A: n=12
B or C=125
L: 12.2cm (4-28cm)

50-99%
Stenosis
Free
Survival
DUPLEX

clinical improvement
Acute stent occlusion is rare (

Mewissen MW. Self-Expanding nitinol stents in the FP segment: technique and mid-term results
Techniques in Vascular and Interventional Radiology. 7(1): 2-5, 2004 Mar

Self-Expanding Nitinol Stents in the FP Segment: Technique and Mid-term Results

Based on Outcome Criteria
PSVR < 2.5

< 5CM 58%

Vienna
286 patients Rx: (1999-2004)
- 88% claudication

Redo PTA (16 pts)
bypass grafting (3 pts)

Reintervention Rate;
Wallstent – 41%
SMART – 24%
Dynalink – 18%

Nonrandomized Comparison
of 3 SFA Stents

FU
Conclusions:
- nitinol stents outperformed
Wallstents in SFA

infra-inguinal Bypass
prior CABG X 2
Case Presentation –

cm/s
In-stent stenosis
Asymptomatic

history in SFA

- 77% 3-yr limb slavage
- duplex surveillance with

lesions randomized
- Quantitiative angiography
found no significant